Strategic Use of New Generation Antidepressants for Depression
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to establish the optimum treatment strategy for first-line and
second-line antidepressants in the acute phase treatment of major depression.
Phase:
Phase 4
Details
Lead Sponsor:
Kyoto University
Collaborator:
National Center of Neurology and Psychiatry, Japan